PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Percuro is a low carbon, next-generation pet food that is ethically farmed and formulated using insect proteins. The company argues that its pet food has a low carbon pawprint whilst being hypoallergenic and nutritious with low inflammation properties. Percuro has launched its Direct-To-Consumer (DTC) site in the UK and Germany with a roll-out plan that includes covering additional EU markets later in 2021, raised a £340,000 seed investment in the previous 10 months, and signed product listing agreements with key retailers in the UK and Singapore. The company will use 40% of the investment for brand building through digital marketing, 30% for retailer brand-building investments, 20% towards launching treats and its plant dog range, and 10% towards new market expansion into Asia.
days to go:
Expired
investment:
£618,596
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.
days to go:
Expired
investment:
£2,160,000
Run3D is a biotechnology company that has developed a 3D gait analysis system with the aim to help people identify injuries, deliver better performance, and make better running decisions. 3D gait analysis involves using infrared cameras to track positions of small reflective markers attached to a person in motion, capturing measurable data to help quantify a person's risk of injury, biomechanical efficiency, performance, footwear, and recommend proper diagnosis where necessary. The company plans to use the investment to grow its business.
days to go:
Expired
investment:
Withheld
The Idle Man is a fast growing internet retailer with experienced founders. Within the third month of trading The Idle Man was already seeing £100,000 in monthly revenue. This funding round they are aiming to use the money gained from investments to continue their aggressive expansion.
days to go:
Expired
investment:
£1,283,974
Doctaly is the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go:
Expired
investment:
£807,580
Lemonade Dolls (LD) is the UK's first subscription underwear brand that aims to make hassle-free and comfortable underwear for young women. The company's revenue has grown 550% since January 2020. The Lemonade Dolls brand is sold in Topshop, New Look, and ASOS Marketplace. LD has 2,600 subscribers, 15,000 Dolls on its database, and over 70,000 followers across LD and Lemon's on Instagram. It also aims to bring audiences different brands like Candy Kittens, Frank Body, Dr Paw Paw, Mooncup, and Oh K!. The company has been praised by fashion magazine Grazia as having 'Broken the mould'. The company will use the investment to develop the technology behind its subscription platform, grow its product offering, strengthen its virtual presence, and drive brand awareness.
days to go:
Expired
investment:
£258,328
